Loading...
Erlotinib in the treatment of advanced pancreatic cancer
Single agent gemcitabine has been the mainstay of therapy for advanced pancreatic cancer over the past decade. Multiple trials of newer chemotherapeutic agents both alone and in combination have yielded disappointing results, spurring the ongoing search for new agents and combinations in this aggres...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2727779/ https://ncbi.nlm.nih.gov/pubmed/19707431 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|